why choose us

First received: November 1, 2022

Clinical Trial: PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT

Study Status: Completed

Recruit Status: Completed

Condition: Prostate Cancer

Study Type: Observational


Official Title: PRO-MR-RT Systematic Web-based Patient-reported Outcomes for a Personalized, Patient-centered Symptom Management and Clinical Assessment of Pelvic Toxicity to Magnetic Resonance Radiation Therapy

Brief Summary: In 2018 the Unity MR-linac was approved for treating patients with online magnetic resonance (MR)-guided radiotherapy. With the MR-linac it is possible to get real-time MR images with high soft tissue contrast, adapt the radiotherapy plan and subsequently irradiate at each treatment fraction. Patients with prostate cancer is one of the patient groups referred for this new treatment and potentially they will benefit with decreased margins around the tumour and increased local tumor control rates.The acute toxicity…

Read more